Clinical and Laboratory Standards Institute guideline C52—Toxicology and Drug Testing in the Medical Laboratory helps medical
laboratories develop procedures for analyzing drugs of abuse and other compounds. C52 provides guidance on clinical toxicology
testing from the initial consultation through final result reporting and interpretation, and includes a variety of specimen types,
analytical procedures, and instrumentation.
This guideline discusses the most common purposes for clinical toxicology testing, including the support of emergency medicine,
obstetrics and gynecology, neonatology, pediatrics, psychiatry, pain management, and addiction medicine. The primary objective
is to ensure high-quality standards are maintained throughout the entire testing process, from specimen collection, processing, and
analysis, through results reporting and interpretation.
Document identifier
CLSI C52
Title
Toxicology and Drug Testing in the Medical Laboratory, Third Edition, C52Ed3E
CLSI Category
Clinical Chemistry and Toxicology
Publication date
2017-01-01
International Relationship
History of version
CLSI C52 * CLSI C52-A2
Price |
140 vnd |